Furthermore, we demonstrate that cinacalcet, a positive CaSR allosteric modulator, ameliorated impaired CaSR-mediated signaling due to rare kidney stone–associated DGKδ missense mutations and normalized biased CaSR signal transduction in DGKδ-depleted cells. Here, DGKD is linked to nephrolithiasis.